The Impact of Lactobacillus plantarum WCFS1 Teichoic Acid D-Alanylation on the Generation of Effector and Regulatory T-cells in Healthy Mice

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Smelt, Maaike J ^a,b   de Haan, Bart J ^b   Bron, Peter A ^a,c,e   van Swam, Iris ^a,c   Meijerink, Marjolein ^a,d   Wells, Jerry M ^a,d   Kleerebezem, Michiel ^a,c,d   Faas, Marijke M ^b   de Vos, Paul ^a,b  

^a TOP INSTITUTE FOOD AND NUTRITION   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c NIZO FOOD RESEARCH   (Netherlands)

^d WAGENINGEN UNIVERSITY   (Netherlands)

^e Kluyver Centre for Fermentation and Genomics   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; DEXTRO ALANINE; INTERLEUKIN 2 RECEPTOR ALPHA; PROBIOTIC AGENT; TEICHOIC ACID; TRANSCRIPTION FACTOR FOXP3; ALANYL-LIPOTEICHOIC ACID; CYTOKINE; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, MOUSE; TOLL LIKE RECEPTOR 2;

ADAPTIVE IMMUNITY; AMINO ACID SUBSTITUTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BACTERIAL MEMBRANE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DENDRITIC CELL; DEXTRO ALANYLATION; EFFECTOR CELL; EMBRYO; FEMALE; HOST PATHOGEN INTERACTION; HUMAN; HUMAN CELL; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; LACTOBACILLUS PLANTARUM; MALE; MESENTERY LYMPH NODE; MOUSE; NONHUMAN; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; SPLEEN; T LYMPHOCYTE ACTIVATION; ANIMAL; CELL LINE; CELL WALL; CHEMISTRY; IMMUNOLOGY; INFLAMMATION; INTESTINE MUCOSA; LYMPH NODE; MESENTERY; METABOLISM; MICROBIOLOGY; PEYER PATCH; T LYMPHOCYTE SUBPOPULATION;

BACTERIA (MICROORGANISMS); LACTOBACILLUS PLANTARUM; MUS; POSIBACTERIA;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE; CELL WALL; CYTOKINES; DENDRITIC CELLS; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; IMMUNOMODULATION; INFLAMMATION; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; INTESTINAL MUCOSA; LACTOBACILLUS PLANTARUM; LYMPH NODES; MALE; MESENTERY; MICE; PEYER'S PATCHES; PROBIOTICS; SIGNAL TRANSDUCTION; SPLEEN; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY; TEICHOIC ACIDS; TOLL-LIKE RECEPTOR 2;

EID: 84877004769     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0063099     Document Type: Article

References (76)

1. Remus DM, Kleerebezem M, Bron PA, (2011) An intimate tete-a-tete- how probiotic lactobacilli communicate with the host. Eur J Pharmacol 668Suppl 1: S33-S42.
2. Bron PA, van Baarlen P, Kleerebezem M, (2011) Emerging molecular insights into the interaction between probiotics and the host intestinal mucosa. Nat Rev Microbiol 10: 66-78.
3. Lebeer S, Vanderleyden J, De Keersmaecker SC (2008) Genes and molecules of lactobacilli supporting probiotic action. Microbiol Mol Biol Rev 72: 728-64, Table of Contents.
4. Kleerebezem M, Boekhorst J, van Kranenburg R, Molenaar D, Kuipers OP, et al. (2003) Complete genome sequence of lactobacillus plantarum WCFS1. Proc Natl Acad Sci U S A 100: 1990-1995.
5. van Baarlen P, Troost FJ, van Hemert S, van der Meer C, de Vos WM, et al. (2009) Differential NF-kappaB pathways induction by lactobacillus plantarum in the duodenum of healthy humans correlating with immune tolerance. Proc Natl Acad Sci U S A 106: 2371-2376.
6. Meijerink M, van Hemert S, Taverne N, Wels M, de Vos P, et al. (2010) Identification of genetic loci in lactobacillus plantarum that modulate the immune response of dendritic cells using comparative genome hybridization. PLoS ONE 5: e10632.
7. van Hemert S, Meijerink M, Molenaar D, Bron PA, de Vos P, et al. (2010) Identification of lactobacillus plantarum genes modulating the cytokine response of human peripheral blood mononuclear cells. BMC Microbiol 10: 293.
8. Bron PA, Tomita S, van SwamII, Remus DM, Meijerink M, et al. (2012) Lactobacillus plantarum possesses the capability for wall teichoic acid backbone alditol switching. Microb Cell Fact 11: 123.
9. Kang SS, Ryu YH, Baik JE, Yun CH, Lee K, et al. (2011) Lipoteichoic acid from lactobacillus plantarum induces nitric oxide production in the presence of interferon-gamma in murine macrophages. Mol Immunol 48: 2170-2177.
10. Ryu YH, Baik JE, Yang JS, Kang SS, Im J, et al. (2009) Differential immunostimulatory effects of gram-positive bacteria due to their lipoteichoic acids. Int Immunopharmacol 9: 127-133.
11. Grangette C, Nutten S, Palumbo E, Morath S, Hermann C, et al. (2005) Enhanced antiinflammatory capacity of a lactobacillus plantarum mutant synthesizing modified teichoic acids. Proc Natl Acad Sci U S A 102: 10321-10326.
12. Hirose Y, Murosaki S, Fujiki T, Yamamoto Y, Yoshikai Y, et al. (2010) Lipoteichoic acids on lactobacillus plantarum cell surfaces correlate with induction of interleukin-12p40 production. Microbiol Immunol 54: 143-151.
13. Morath S, von Aulock S, Hartung T, (2005) Structure/function relationships of lipoteichoic acids. J Endotoxin Res 11: 348-356.
14. Xia G, Kohler T, Peschel A, (2010) The wall teichoic acid and lipoteichoic acid polymers of staphylococcus aureus. Int J Med Microbiol 300: 148-154.
15. Kleerebezem M, Hols P, Bernard E, Rolain T, Zhou M, et al. (2010) The extracellular biology of the lactobacilli. FEMS Microbiol Rev 34: 199-230.
16. Rockel C, Hartung T, Hermann C, (2011) Different staphylococcus aureus whole bacteria mutated in putative pro-inflammatory membrane components have similar cytokine inducing activity. Immunobiology 216: 316-321.
17. Wells JM, (2011) Immunomodulatory mechanisms of lactobacilli. Microb Cell Fact 10Suppl 1: S17.
18. Claes IJ, Lebeer S, Shen C, Verhoeven TL, Dilissen E, et al. (2010) Impact of lipoteichoic acid modification on the performance of the probiotic lactobacillus rhamnosus GG in experimental colitis. Clin Exp Immunol 162: 306-314.
19. Mohamadzadeh M, Pfeiler EA, Brown JB, Zadeh M, Gramarossa M, et al. (2011) Regulation of induced colonic inflammation by lactobacillus acidophilus deficient in lipoteichoic acid. Proc Natl Acad Sci U S A 108Suppl 1: 4623-4630.
20. Saber R, Zadeh M, Pakanati KC, Bere P, Klaenhammer T, et al. (2011) Lipoteichoic acid-deficient lactobacillus acidophilus regulates downstream signals. Immunotherapy 3: 337-347.
21. Zadeh M, Khan MW, Goh YJ, Selle K, Owen JL, et al. (2012) Induction of intestinal pro-inflammatory immune responses by lipoteichoic acid. J Inflamm (Lond) 9: 7-9255-9-7.
22. Khazaie K, Zadeh M, Khan MW, Bere P, Gounari F, et al. (2012) Abating colon cancer polyposis by lactobacillus acidophilus deficient in lipoteichoic acid. Proc Natl Acad Sci U S A 109: 10462-10467.
23. Vaughan EE, de Vries MC, Zoetendal EG, Ben-Amor K, Akkermans AD, et al. (2002) The intestinal LABs. Antonie Van Leeuwenhoek 82: 341-352.
24. Foligne B, Nutten S, Grangette C, Dennin V, Goudercourt D, et al. (2007) Correlation between in vitro and in vivo immunomodulatory properties of lactic acid bacteria. World J Gastroenterol 13: 236-243.
25. Foligne B, Dessein R, Marceau M, Poiret S, Chamaillard M, et al. (2007) Prevention and treatment of colitis with lactococcus lactis secreting the immunomodulatory yersinia LcrV protein. Gastroenterology 133: 862-874.
26. Marco ML, Bongers RS, de Vos WM, Kleerebezem M, (2007) Spatial and temporal expression of lactobacillus plantarum genes in the gastrointestinal tracts of mice. Appl Environ Microbiol 73: 124-132.
27. Lutz MB, Kukutsch N, Ogilvie AL, Rossner S, Koch F, et al. (1999) An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J Immunol Methods 223: 77-92.
28. Denning TL, Norris BA, Medina-Contreras O, Manicassamy S, Geem D, et al. (2011) Functional specializations of intestinal dendritic cell and macrophage subsets that control Th17 and regulatory T cell responses are dependent on the T cell/APC ratio, source of mouse strain, and regional localization. J Immunol 187: 733-747.
29. Mosmann TR, Coffman RL, (1989) TH1 and TH2 cells: Different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 7: 145-173.
30. Zhu J, Yamane H, Paul WE, (2010) Differentiation of effector CD4 T cell populations (*). Annu Rev Immunol 28: 445-489.
31. Maddur MS, Miossec P, Kaveri SV, Bayry J (2012) Th17 cells: Biology, pathogenesis of autoimmune and inflammatory diseases, and therapeutic strategies. Am J Pathol.
32. Jacobo P, Perez CV, Theas MS, Guazzone VA, Lustig L, (2011) CD4+ and CD8+ T cells producing Th1 and Th17 cytokines are involved in the pathogenesis of autoimmune orchitis. Reproduction 141: 249-258.
33. Mimura T, Rizzello F, Helwig U, Poggioli G, Schreiber S, et al. (2004) Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis. Gut 53: 108-114.
34. Gionchetti P, Rizzello F, Helwig U, Venturi A, Lammers KM, et al. (2003) Prophylaxis of pouchitis onset with probiotic therapy: A double-blind, placebo-controlled trial. Gastroenterology 124: 1202-1209.
35. Gosselink MP, Schouten WR, van Lieshout LM, Hop WC, Laman JD, et al. (2004) Delay of the first onset of pouchitis by oral intake of the probiotic strain lactobacillus rhamnosus GG. Dis Colon Rectum 47: 876-884.
36. Kruis W, Fric P, Pokrotnieks J, Lukas M, Fixa B, et al. (2004) Maintaining remission of ulcerative colitis with the probiotic escherichia coli nissle 1917 is as effective as with standard mesalazine. Gut 53: 1617-1623.
37. Tursi A, Brandimarte G, Giorgetti GM, Forti G, Modeo ME, et al. (2004) Low-dose balsalazide plus a high-potency probiotic preparation is more effective than balsalazide alone or mesalazine in the treatment of acute mild-to-moderate ulcerative colitis. Med Sci Monit 10: PI126-31.
38. Guandalini S, Magazzu G, Chiaro A, La Balestra V, Di Nardo G, et al. (2010) VSL#3 improves symptoms in children with irritable bowel syndrome: A multicenter, randomized, placebo-controlled, double-blind, crossover study. J Pediatr Gastroenterol Nutr 51: 24-30.
39. Guandalini S, (2002) Use of lactobacillus-GG in paediatric crohn's disease. Dig Liver Dis 34Suppl 2: S63-5.
40. Hojsak I, Abdovic S, Szajewska H, Milosevic M, Krznaric Z, et al. (2010) Lactobacillus GG in the prevention of nosocomial gastrointestinal and respiratory tract infections. Pediatrics 125: e1171-e1177.
41. Boge T, Remigy M, Vaudaine S, Tanguy J, Bourdet-Sicard R, et al. (2009) A probiotic fermented dairy drink improves antibody response to influenza vaccination in the elderly in two randomised controlled trials. Vaccine 27: 5677-5684.
42. Paineau D, Carcano D, Leyer G, Darquy S, Alyanakian MA, et al. (2008) Effects of seven potential probiotic strains on specific immune responses in healthy adults: A double-blind, randomized, controlled trial. FEMS Immunol Med Microbiol 53: 107-113.
43. Davidson LE, Fiorino AM, Snydman DR, Hibberd PL, (2011) Lactobacillus GG as an immune adjuvant for live-attenuated influenza vaccine in healthy adults: A randomized double-blind placebo-controlled trial. Eur J Clin Nutr 65: 501-507.
44. Kalliomaki M, Salminen S, Poussa T, Arvilommi H, Isolauri E, (2003) Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial. Lancet 361: 1869-1871.
45. Isolauri E, Arvola T, Sutas Y, Moilanen E, Salminen S, (2000) Probiotics in the management of atopic eczema. Clin Exp Allergy 30: 1604-1610.
46. Meijer K, de Vos P, Priebe MG, (2010) Butyrate and other short-chain fatty acids as modulators of immunity: What relevance for health? Curr Opin Clin Nutr Metab Care 13: 715-721.
47. Hatakka K, Savilahti E, Ponka A, Meurman JH, Poussa T, et al. (2001) Effect of long term consumption of probiotic milk on infections in children attending day care centres: Double blind, randomised trial. BMJ 322: 1327.
48. Kwon HK, Lee CG, So JS, Chae CS, Hwang JS, et al. (2010) Generation of regulatory dendritic cells and CD4+Foxp3+ T cells by probiotics administration suppresses immune disorders. Proc Natl Acad Sci U S A 107: 2159-2164.
49. So JS, Kwon HK, Lee CG, Yi HJ, Park JA, et al. (2008) Lactobacillus casei suppresses experimental arthritis by down-regulating T helper 1 effector functions. Mol Immunol 45: 2690-2699.
50. Calcinaro F, Dionisi S, Marinaro M, Candeloro P, Bonato V, et al. (2005) Oral probiotic administration induces interleukin-10 production and prevents spontaneous autoimmune diabetes in the non-obese diabetic mouse. Diabetologia 48: 1565-1575.
51. Foligne B, Zoumpopoulou G, Dewulf J, Ben YA, Chareyre F, et al. (2007) A key role of dendritic cells in probiotic functionality. PLoS ONE 2: e313.
52. Matsumoto S, Hara T, Hori T, Mitsuyama K, Nagaoka M, et al. (2005) Probiotic lactobacillus-induced improvement in murine chronic inflammatory bowel disease is associated with the down-regulation of pro-inflammatory cytokines in lamina propria mononuclear cells. Clin Exp Immunol 140: 417-426.
53. O'Hara AM, O'Regan P, Fanning A, O'Mahony C, MacSharry J, et al. (2006) Functional modulation of human intestinal epithelial cell responses by bifidobacterium infantis and lactobacillus salivarius. Immunology 118: 202-215.
54. Niers LE, Timmerman HM, Rijkers GT, van Bleek GM, van Uden NO, et al. (2005) Identification of strong interleukin-10 inducing lactic acid bacteria which down-regulate T helper type 2 cytokines. Clin Exp Allergy 35: 1481-1489.
55. Miettinen M, Matikainen S, Vuopio-Varkila J, Pirhonen J, Varkila K, et al. (1998) Lactobacilli and streptococci induce interleukin-12 (IL-12), IL-18, and gamma interferon production in human peripheral blood mononuclear cells. Infect Immun 66: 6058-6062.
56. Smelt MJ, de Haan BJ, Bron PA, van Swam I, Meijerink M, et al. (2012) L. plantarum, L. salivarius, and L. lactis attenuate Th2 responses and increase treg frequencies in healthy mice in a strain dependent manner. PLoS One 7: e47244.
57. Ryu YH, Baik JE, Yang JS, Kang SS, Im J, et al. (2009) Differential immunostimulatory effects of gram-positive bacteria due to their lipoteichoic acids. Int Immunopharmacol 9: 127-133.
58. Foligne B, Nutten S, Steidler L, Dennin V, Goudercourt D, et al. (2006) Recommendations for improved use of the murine TNBS-induced colitis model in evaluating anti-inflammatory properties of lactic acid bacteria: Technical and microbiological aspects. Dig Dis Sci 51: 390-400.
59. Turner JR, (2009) Intestinal mucosal barrier function in health and disease. Nat Rev Immunol 9: 799-809.
60. Fuss IJ, Neurath M, Boirivant M, Klein JS, de la Motte C, et al. (1996) Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5. J Immunol 157: 1261-1270.
61. Knox KW, Wicken AJ, (1972) Serological studies on the teichoic acids of lactobacillus plantarum. Infect Immun 6: 43-49.
62. Campbell LK, Knox KW, Wicken AJ, (1978) Extractability of cell wall polysaccharide from lactobacilli and streptococci by autoclaving and by dilue acid. Infect Immun 22: 842-851.
63. Takeda K, Akira S, (2004) TLR signaling pathways. Semin Immunol 16: 3-9.
64. Yamazaki S, Okada K, Maruyama A, Matsumoto M, Yagita H, et al. (2011) TLR2-dependent induction of IL-10 and Foxp3+ CD25+ CD4+ regulatory T cells prevents effective anti-tumor immunity induced by Pam2 lipopeptides in vivo. PLoS One 6: e18833.
65. Manicassamy S, Ravindran R, Deng J, Oluoch H, Denning TL, et al. (2009) Toll-like receptor 2-dependent induction of vitamin A-metabolizing enzymes in dendritic cells promotes T regulatory responses and inhibits autoimmunity. Nat Med 15: 401-409.
66. Aumeunier A, Grela F, Ramadan A, Pham Van L, Bardel E, et al. (2010) Systemic toll-like receptor stimulation suppresses experimental allergic asthma and autoimmune diabetes in NOD mice. PLoS One 5: e11484.
67. Dennehy KM, Willment JA, Williams DL, Brown GD, (2009) Reciprocal regulation of IL-23 and IL-12 following co-activation of dectin-1 and TLR signaling pathways. Eur J Immunol 39: 1379-1386.
68. Chen Q, Davidson TS, Huter EN, Shevach EM, (2009) Engagement of TLR2 does not reverse the suppressor function of mouse regulatory T cells, but promotes their survival. J Immunol 183: 4458-4466.
69. Palumbo E, Deghorain M, Cocconcelli PS, Kleerebezem M, Geyer A, et al. (2006) D-alanyl ester depletion of teichoic acids in lactobacillus plantarum results in a major modification of lipoteichoic acid composition and cell wall perforations at the septum mediated by the Acm2 autolysin. J Bacteriol 188: 3709-3715.
70. Hansson GC, Johansson ME, (2010) The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria. Gut Microbes 1: 51-54.
71. Johansson ME, Phillipson M, Petersson J, Velcich A, Holm L, et al. (2008) The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria. Proc Natl Acad Sci U S A 105: 15064-15069.
72. Johansson ME, Gustafsson JK, Sjoberg KE, Petersson J, Holm L, et al. (2010) Bacteria penetrate the inner mucus layer before inflammation in the dextran sulfate colitis model. PLoS One 5: e12238.
73. van der Waaij LA, Harmsen HJ, Madjipour M, Kroese FG, Zwiers M, et al. (2005) Bacterial population analysis of human colon and terminal ileum biopsies with 16S rRNA-based fluorescent probes: Commensal bacteria live in suspension and have no direct contact with epithelial cells. Inflamm Bowel Dis 11: 865-871.
74. O'Flaherty S, Saulnier DM, Pot B, Versalovic J, (2010) How can probiotics and prebiotics impact mucosal immunity? Gut Microbes 1: 293-300.
75. Marco ML, Pavan S, Kleerebezem M, (2006) Towards understanding molecular modes of probiotic action. Curr Opin Biotechnol 17: 204-210.
76. Tsilingiri K, Barbosa T, Penna G, Caprioli F, Sonzogni A, et al. (2012) Probiotic and postbiotic activity in health and disease: Comparison on a novel polarised ex-vivo organ culture model. Gut 61: 1007-1015.